They studied tumor growth in IL-10-deficient (IL-10−/−) mice and found that endogenous IL-10 inhibits inflammatory cytokine production and hampers the development of Treg cells and myeloid-derived suppressor cells, two key components of the immunosuppressive tumor microenvironment, thereby inhibiting tumor development, growth, and metastasis. This evidence concerns the gene IL10 and neoplasm.